Meet the Team

Nermeen is a healthcare and life sciences business leader, who founded, built and exited a number of multinational start up and corporate businesses. She has deep expertise in clinical development, translational medicine and medical affairs having held executive positions in contract research organisations and biopharmaceutical companies.

Andrew is Chief Executive Officer at CRISM Therapeutics, a platform drug delivery technology company. The Company's lead product, ChemoSeed is for the treatment of brain tumour. Future indications may include pancreatic, prostate, bladder and breast cancers.

Chris is Director and Chief Scientific Officer at CRISM Therapeutics a company set up to provide expert advice and consultancy on the use of hot melt extrusion, injection moulding and 3D printing within the pharmaceutical industry. Chris is the inventor of ChemoSeed, the Company's implantable biodegradable drug delivery technology.

Gerry is a consultant to growth companies seeking strategic advice or funding for expansion. He was a non-executive director of Spectral MD Holdings Ltd (subsequently renamed Spectral AI, Inc.) a medical technology company quoted on AIM between June 2021 and September 2023.